Index of reports
> Life Threatening Events (19)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Mozobil (Plerixafor Subcutaneous) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Mozobil side effects in female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-08-22
Patient: female
Reactions: Pulmonary Embolism, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Mozobil
Indication: Lymphoma Transformation
Mozobil
Dosage: 15.36 mg, qd
Indication: Haematopoietic Stem Cell Mobilisation
Start date: 2011-04-27
End date: 2011-04-29
Other drugs received by patient: Neupogen; Terbinafine HCL; Centyl MED Kaliumklorid; Acyclovir
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-08-21
Patient: female, weighing 25.0 kg (55.0 pounds)
Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Cardiac Failure, Respiratory Failure, Sepsis, Pleural Effusion, Hypertension, Fusarium Infection
Adverse event resulted in: death, life threatening event, disablity
Drug(s) suspected as cause:
Clolar
Dosage: 70 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-10
End date: 2012-01-11
Fludara
Dosage: 140 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-11
End date: 2012-06-15
Mozobil
Dosage: 6 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-16
End date: 2012-06-18
Thymoglobulin
Dosage: 254 mg, qd
Start date: 2012-06-16
End date: 2012-06-19
Thymoglobulin
Dosage: 229.9 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-15
End date: 2012-01-18
Other drugs received by patient: Meropenem; Fentanyl Citrate; Cytarabine; Thiotepa; Melphalan Hydrochloride; Dilaudid; Busulfan
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-08-21
Patient: female, weighing 25.0 kg (55.0 pounds)
Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Respiratory Failure, Cardiac Failure, Sepsis, Pleural Effusion, Fusarium Infection, Hypertension
Adverse event resulted in: death, life threatening event, disablity
Drug(s) suspected as cause:
Clolar
Dosage: 70 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-10
End date: 2012-01-11
Fludara
Dosage: 140 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-11
End date: 2012-06-15
Mozobil
Dosage: 6 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-16
End date: 2012-06-18
Thymoglobulin
Dosage: 229.9 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-15
End date: 2012-01-18
Thymoglobulin
Dosage: 254 mg, qd
Start date: 2012-06-16
End date: 2012-06-19
Other drugs received by patient: Busulfan; Thiotepa; Dilaudid; Meropenem; Cytarabine; Melphalan Hydrochloride; Fentanyl Citrate
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-08-16
Patient: female, weighing 25.2 kg (55.4 pounds)
Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Cardiac Failure, Respiratory Failure, Sepsis, Pleural Effusion, Fusarium Infection, Hypertension
Adverse event resulted in: death, life threatening event, disablity
Drug(s) suspected as cause:
Clolar
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-10
End date: 2012-01-11
Fludara
Dosage: 140 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-11
End date: 2012-06-15
Mozobil
Dosage: 6 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-16
End date: 2012-06-18
Thymoglobulin
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-15
End date: 2012-01-18
Thymoglobulin
Dosage: unk
Start date: 2012-06-16
End date: 2012-06-19
Other drugs received by patient: Melphalan Hydrochloride; Busulfan; Fentanyl; Thiotepa; Cytarabine; Dilaudid; Meropenem
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-08-13
Patient: female, weighing 25.2 kg (55.4 pounds)
Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Respiratory Failure, Cardiac Failure, Sepsis, Pleural Effusion, Fusarium Infection, Hypertension
Adverse event resulted in: death, life threatening event, disablity
Drug(s) suspected as cause:
Clolar
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-10
End date: 2012-01-11
Fludara
Dosage: 140 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-11
End date: 2012-06-15
Mozobil
Dosage: 6 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-16
End date: 2012-06-18
Thymoglobulin
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-15
End date: 2012-01-18
Thymoglobulin
Dosage: unk
Start date: 2012-06-16
End date: 2012-06-19
Other drugs received by patient: Meropenem; Melphalan Hydrochloride; Cytarabine; Busulfan; Dilaudid; Fentanyl; Thiotepa
Possible Mozobil side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-24
Patient: female, weighing 85.9 kg (189.0 pounds)
Reactions: White Blood Cell Count Decreased, Acute Myeloid Leukaemia, Pulmonary Alveolar Haemorrhage, Febrile Neutropenia, Lung Infection Pseudomonal, Pseudomonal Bacteraemia, Multi-Organ Failure, Respiratory Failure, Platelet Count Decreased, Cardiac Arrest, Septic Shock
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Mozobil
Other drugs received by patient: Neupogen; Carvedilol; Cefpodoxime Proxetil; Polyethylene Glycol; Valacyclovir Hydrochloride; Furosemide; Fluconazole; Temazepam; Fluticasone W; Tramadol HCL; Lansoprazole; Nifedipine; Nifedipine; Docusate Sodium W; Ondansetron Hydrochloride; Potassium Chloride; Levothyroxine Sodium; Sorafenib; Heparin; Lisinopril
Possible Mozobil side effects in female
Reported by a physician from Denmark on 2012-06-07
Patient: female
Reactions: Pulmonary Embolism
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Mozobil
Dosage: unk
Indication: Haematopoietic Stem Cell Mobilisation
Start date: 2011-04-27
End date: 2011-04-29
Mozobil
Indication: Lymphoma Transformation
Other drugs received by patient: Neupogen; Centyl MED Kaliumklorid; Acyclovir; Terbinafine HCL
Possible Mozobil side effects in female
Reported by a physician from Denmark on 2012-05-31
Patient: female
Reactions: Pulmonary Embolism
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Mozobil
Indication: Lymphoma Transformation
Mozobil
Dosage: unk
Indication: Haematopoietic Stem Cell Mobilisation
Start date: 2011-04-27
End date: 2011-04-29
Other drugs received by patient: Centyl MED Kaliumklorid; Neupogen; Terbinafine HCL; Acyclovir
Possible Mozobil side effects in 59 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-23
Patient: 59 year old female
Reactions: Sinusitis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Granulocyte Colony Stimulating Factor
Dosage: 10 mcg/kg, qd; days 1-5
Indication: Myelodysplastic Syndrome
Mozobil
Dosage: days 1-5
Indication: Myelodysplastic Syndrome
Vidaza
Dosage: 75 mg/m2, qd; days 1-5
Indication: Myelodysplastic Syndrome
Possible Mozobil side effects in male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-17
Patient: male, weighing 110.0 kg (242.0 pounds)
Reactions: Anaphylactic Reaction
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Mozobil
Other drugs received by patient: Granulocyte Colony Stimulating Factor
Possible Mozobil side effects in male
Reported by a physician from United Kingdom on 2012-05-02
Patient: male, weighing 110.0 kg (242.0 pounds)
Reactions: Anaphylactic Reaction
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Mozobil
Other drugs received by patient: Granulocyte Colony Stimulating Factor
Possible Mozobil side effects in male
Reported by a physician from United Kingdom on 2012-04-17
Patient: male, weighing 110.0 kg (242.0 pounds)
Reactions: Anaphylactic Reaction
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Mozobil
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-04-17
Patient: female, weighing 59.7 kg (131.3 pounds)
Reactions: Pulmonary Embolism, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-03-08
Daunorubicin HCL
Indication: Acute Myeloid Leukaemia
Mozobil
Dosage: 480 mcg/kg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2011-01-08
End date: 2011-01-13
Neocon
Dosage: unk
Indication: Vaginal Haemorrhage
Start date: 2011-02-09
End date: 2011-02-09
Other drugs received by patient: Meropenem; Allopurinol; Flagyl; Abelcet; Acyclovir; Provera; Vancomycin
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-03-13
Patient: female, weighing 59.7 kg (131.3 pounds)
Reactions: Pulmonary Embolism, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-03-08
Daunorubicin HCL
Indication: Acute Myeloid Leukaemia
Mozobil
Dosage: 480 mcg/kg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2011-01-08
End date: 2011-01-13
Neocon
Dosage: unk
Indication: Vaginal Haemorrhage
Start date: 2011-02-09
End date: 2011-02-09
Other drugs received by patient: Meropenem; Acyclovir; Abelcet; Flagyl; Allopurinol; Provera; Vancomycin
Possible Mozobil side effects in male
Reported by a physician from Korea, Republic of on 2012-01-27
Patient: male, weighing 20.4 kg (44.9 pounds)
Reactions: Interstitial Lung Disease, Febrile Neutropenia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Mozobil
Dosage: 4.7 mg, qd
Indication: Haematopoietic Stem Cell Mobilisation
Start date: 2010-11-14
End date: 2010-11-15
Mozobil
Indication: Medulloblastoma
Other drugs received by patient: Neupogen
Possible Mozobil side effects in male
Reported by a consumer/non-health professional from Korea, Republic of on 2012-01-20
Patient: male, weighing 20.4 kg (44.9 pounds)
Reactions: Interstitial Lung Disease, Febrile Neutropenia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Mozobil
Indication: Medulloblastoma
Mozobil
Dosage: 4.7 mg, qd
Indication: Haematopoietic Stem Cell Mobilisation
Start date: 2010-11-14
End date: 2010-11-15
Other drugs received by patient: Neupogen
Possible Mozobil side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2011-12-07
Patient: female
Reactions: Myelodysplastic Syndrome
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Alkeran
Dosage: 16 milligram
Administration route: Oral
Start date: 2007-10-01
End date: 2008-01-01
Alkeran
Dosage: 200 mg/m2 depending on cycle
Administration route: Oral
Start date: 2003-10-01
End date: 2003-10-01
Cyclophosphamide
Dosage: 4ug/m2 depending on cylce
Start date: 2003-05-27
End date: 2003-05-27
Dexamethasone
Administration route: Oral
Start date: 2003-02-01
End date: 2003-08-01
Dexamethasone
Dosage: depending on cycle
Administration route: Oral
Start date: 2009-12-12
End date: 2010-10-01
Doxorubicin HCL
Start date: 2003-02-01
End date: 2003-01-01
Granocyte
Dosage: 800 ug, depending on cycle
Start date: 2011-06-12
End date: 2011-06-18
Mozobil
Dosage: depending on cycle
Start date: 2011-06-13
End date: 2011-06-16
Prednisolone
Dosage: 170 milligram
Administration route: Oral
Start date: 2007-10-01
End date: 2008-01-01
Revlimid
Dosage: 25 milligram
Administration route: Oral
Start date: 2009-12-12
End date: 2010-10-01
Velcade
Dosage: depending on cycle
Start date: 2007-10-01
End date: 2008-01-01
Vincristine
Start date: 2003-02-01
End date: 2003-08-01
Possible Mozobil side effects in male
Reported by a physician from Korea, Republic of on 2011-12-02
Patient: male, weighing 20.4 kg (44.9 pounds)
Reactions: Interstitial Lung Disease, Febrile Neutropenia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Mozobil
Other drugs received by patient: Neupogen
Possible Mozobil side effects in male
Reported by a consumer/non-health professional from Korea, Republic of on 2011-10-25
Patient: male, weighing 20.4 kg (44.9 pounds)
Reactions: Interstitial Lung Disease, Febrile Neutropenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Mozobil
|